Lynell T. Wright, Pharm.D., Ma Organizational Leadership Email & Phone Number

Tokyo, JP

• Executes the medical strategy with the desired outcome of improving a patient's journey by educating on the importance of access to specialty care, timely diagnosis, and attack prevention with Lanadelumab, Takhzyro, a.
• Supported expanded indication launch of Takhzyro to include pediatric patients. This indication expands LTP therapy to patients 2 - less than 12 years of age.
• Address lack of diversity in clinical trials (moderate psoriasis) by reviewing digital and print recruitment material ensuring language/imagery represents a diverse demographic e.g. age, race, ethnicity.

Newport Beach, California, US

• Builds relationships with dermatologists, plastic surgeons and aesthetic providers to facilitate the adoption of Jeuveau in clinical practice.
• Formulated the 2020 Medical Science Liaison deployment plan composed of strategic objectives and tactics.
• Compliantly collaborated with 14 Regional Sales Managers, 2 Senior Area Directors, 2 Training Managers, and 2 Marketing Managers supporting the launch of Jeuveau resulting in product adoption by 5,000 accounts within 6.

Mumbai, Maharastra, IN

• Led retention efforts for members of the Medical Affairs (MSL) organization. Invited by Chief Medical Officer to represent Field Medical on the "Best-In-Class" initiative, an innovative integration and recognition.
• Developed relationships with dermatologists and other health providers specialized in treating acne and psoriasis.
• Launched ILUMYA™, the first interleukin-23 (IL-23) antagonist FDA approved for the treatment of adults with moderate to severe plaque psoriasis. Expanded ILUMYA™ brand footprint by providing advanced training to.

Dublin, Coolock, IE

• Cultivated relationships with plastic surgeon thought leaders across 10 states for SERI® Surgical Scaffold and Natrelle® Breast Implants. Facilitated the education and research interests of neurologists, physiatrists.
• Identified thought leaders and research sites to support clinical development initiatives and milestones.
• Project co-lead in support of BOTOX® for chronic migraine launch activities: Designed and developed resource documents and training materials for team of 20 MSLs to ensure dissemination of accurate, non-biased content.
• Appointed Movement Disorder Lead by management team within 6 months of hire.
• Trained 35 new employees on science of botulinum toxins in cervical dystonia.
• Selected as Regional Field Training Manager in support of expansion and strategic execution.

Doctor Of Pharmacy (Pharm.D.), Pharmacy

Bachelor Of Science (B.S.), Pharmacy